Valuation: LivaNova PLC

Market Cap 4.44B 3.99B 3.69B 3.34B 6.24B 423B 6.31B 44.07B 17.55B 221B 16.68B 16.32B 703B P/E 2026 *
20.2x
P/E 2027 * 24.3x
Enterprise Value 4.52B 4.05B 3.75B 3.39B 6.34B 430B 6.42B 44.82B 17.85B 225B 16.96B 16.6B 715B EV / Sales 2026 *
2.97x
EV / Sales 2027 * 2.67x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day+1.17%
1 week+1.02%
Current month+7.32%
1 month+6.64%
3 months+0.82%
6 months+39.34%
Current year+33.43%
1 week 79.67
Extreme 79.67
82.28
1 month 74.23
Extreme 74.23
82.28
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/9/26 Free

General Counsel

6,291 0.0114%
10/9/26 Sell

Director

-3,500 0.0064%
4/9/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
+1.17%+1.02%+53.92%+71.36% 4.44B
+0.85%+1.32%-16.53%+11.68% 178B
+2.20%+1.34%-15.80%+18.52% 117B
+1.85%+0.12%+5.43%+38.22% 116B
+0.56%+0.79%-43.91%+6.10% 91.03B
+0.99%-3.11%-1.56%+76.89% 61.89B
-0.32%-0.66%+10.51%+81.65% 55.85B
+0.55%-1.95%+8.26%-21.74% 53.16B
+1.51%+1.04%-8.77%+44.46% 44.35B
+1.68%+1.69%-1.01%-6.87% 33.59B
Average +1.09%+1.14%-0.95%+32.03% 75.45B
Weighted average by Cap. +1.14%+1.26%-9.80%+25.77%

Financials

2026 *2027 *
Net sales 1.52B 1.37B 1.26B 1.14B 2.14B 145B 2.16B 15.1B 6.01B 75.86B 5.71B 5.59B 241B 1.63B 1.46B 1.35B 1.22B 2.29B 155B 2.32B 16.17B 6.44B 81.24B 6.12B 5.99B 258B
Net income 226M 203M 188M 170M 318M 21.55B 321M 2.24B 894M 11.28B 849M 831M 35.8B 187M 168M 155M 140M 262M 17.8B 266M 1.85B 738M 9.32B 701M 687M 29.57B
Net Debt 75M 67.29M 62.21M 56.34M 105M 7.14B 107M 744M 296M 3.74B 281M 276M 11.87B -85M -76.26M -70.51M -63.86M -119M -8.1B -121M -843M -336M -4.24B -319M -312M -13.45B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
30/10/26 USD 82.08 +1.75% 83,269
28/10/26 USD 80.66 +0.35% 550,584
27/10/26 USD 80.38 -0.30% 383,597
26/10/26 USD 80.62 -0.35% 362,375
23/10/26 USD 80.90 -0.46% 572,063
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
80.66USD
Average target price
90.55USD
Spread / Average Target
+12.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LivaNova PLC
  1. Stock Market
  2. Stocks
  3. LIVN Stock